Human Genome Project

Human Genome Project (HGP): The Human Genome Project was an international mega-project launched in 1990 to identify all the genes in human DNA and determine the sequence of the entire human genome; the project was completed in 2003.

Why was it called a mega-project?

• It involved a very large amount of biological data and required advanced computing for storage and analysis.​
• It required international collaboration among many countries and institutions.​
• The human genome contains about 3 billion base pairs, so sequencing it was a major scientific challenge.

• It was coordinated mainly by the U.S. Department of Energy and the National Institutes of Health, with participation from scientists across many countries.​
• The project produced the first reference sequence of the human genome and transformed biological research.​

The major goals of the Human Genome Project were the following:

1. Identify all the genes present in human DNA.
2. Determine the sequence of about 3 billion base pairs in the human genome.
3. Store the generated information in databases for scientific use.​
4. Develop faster and more accurate tools for data analysis.
5. Transfer related technologies to industries and other sectors.​
6. Address ethical, legal, and social issues arising from genome research.​

The project followed a broad sequence of steps to study the human genome.​​

Steps:

1. Isolation of DNA from cells.​
2. Breaking DNA into smaller fragments.​
3. Cloning fragments into suitable vectors such as BACs and YACs for maintenance and study.​​
4. Sequencing the DNA fragments using automated methods.​​
5. Arranging overlapping sequences with the help of computers.​​
6. Identifying genes and assigning possible functions through sequence annotation.​​

The Human Genome Project revealed several important facts about the human genome.

• The human genome contains about 3 billion base pairs.
• The estimated number of genes is about 20,000 to 25,000.
• Less than 2 percent of the genome codes for proteins.
• A large part of the genome consists of non-coding DNA, including repetitive sequences.
• The DNA sequence is approximately 99.9 percent identical among all humans.
• The remaining small percentage of variation contributes to differences among individuals.​
• Many variation sites in the human genome are due to SNPs (single-nucleotide polymorphisms).​

The Human Genome Project has many important applications in biology and medicine.

• It helps in locating genes associated with inherited disorders.​
• It supports early diagnosis and better understanding of genetic diseases.
• It improves the study of gene function and regulation.​
• It supports the development of personalised and precision medicine.​
• It helps in evolutionary studies and comparisons among organisms.​
• It strengthens biotechnology, pharmacogenomics, and modern biological research.​

Genome information is highly useful, but it also raises important ethical and social concerns.​

• Genetic information must be handled with privacy and confidentiality.​
• Misuse of genome data may lead to discrimination in insurance, employment, or social treatment.​
• Genetic knowledge should be applied responsibly and not used to stigmatise individuals or communities.​

• The Human Genome Project (HGP) was an international mega-project launched in 1990 and completed in 2003, coordinated mainly by the U.S. DOE and NIH.
• Its aim was to identify all human genes and sequence the entire human genome of about 3 billion base pairs.
• The main goals were to identify genes, sequence the genome, store the data, develop analysis tools, transfer technologies, and address ethical issues.
• Methodology: DNA was isolated, fragmented, cloned into vectors like BACs and YACs, sequenced by automated methods, and assembled using computers.
• Salient features: the genome has ~3 billion base pairs and 20,000–25,000 genes; less than 2% codes for proteins, and humans are 99.9% identical.
• Most genetic variation between individuals is due to SNPs (single-nucleotide polymorphisms).
• Applications: disease gene mapping, early diagnosis, personalised medicine, evolutionary studies, and advances in biotechnology.
• ELSI (Ethical, Legal, Social Issues): genome data must be kept confidential to prevent misuse and discrimination.